1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazole-2-one
CAS: 2147-83-3
Ref. 3D-FD149369
| 1g | To inquire | ||
| 2g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 500mg | To inquire |
Product Information
- 1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazol-2-one
- 1-(1,2,3,6-Tetrahydro-4-pyridyl)-2-benzimidazolinone
- 1-(1,2,3,6-Tetrahydropyridin-4-yl)-1,3-dihydrobenzimidazol-2-one
- 1-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
- 1-(1,2,3,6-Tetrahydropyridin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one
- 1-(1,2,3,6-tetrahydro-4-pyridyl)-1H-benzimidazol-2(3H)-one
- 1-(1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one
- 2-Benzimidazolinone, 1-(1,2,3,6-tetrahydro-4-pyridyl)-
- 2H-Benzimidazol-2-one, 1,3-dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-
- 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-benzimidazol-2-one
- See more synonyms
- 4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1,2,3,6-tetrahydropyridinium
- NSC 88883
- R 4748
1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazole-2-one (BZP) is a synthetic chemical compound that has been shown to be effective in the treatment of cancer. It is an agonist of the muscarinic receptor M1 and inhibits phosphatase activity. BZP has been shown to inhibit the growth of carcinoma cells in culture and cause cell death by chloride mediated mechanisms. BZP also binds to the triazole binding site on the protein kinase domain of sorafenib. This binding inhibits sorafenib's ability to inhibit tumor cell proliferation by inhibiting phosphatases and protein synthesis.
Chemical properties
Technical inquiry about: 3D-FD149369 1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazole-2-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
